Key result
COX-1 and COX-2 mutations may be associated with recurrent coronary artery disease due to acetylsalicylic acid resistance.
Why the study?
Recurrent CAD can occur due to acetylsalicylic acid resistance, which may be related to genetic factors, prompting investigation into the effects of COX-1 and COX-2 mutations.
Key points are not available for this paper at this time.
Comparison
Effects of COX-1 and COX-2 mutations in recurrent CAD due to acetylsalicylic acid resistance
Answers are grounded in this paper and cite their sources.
C allele of COX-2 was associated with AR in recurrent CAD; leaves open causal role and clinical utility.
Objective: Acetylsalicylic acid (ASA) is a commonly used antiplatelet drug for the treatment of coronary artery disease (CAD). However, in some patients recurrent CAD occurs due to ASA resistance (AR). This condition may be related to some genetic factors. Therefore, this study aims to investigate the effects of cyclooxygenase (COX)-1 and COX-2 mutations on recurrent CAD due to AR.
No takes yet. Share an insight, caveat, or question.
Kıraç et al. (2022) studied this question. COX-1 and COX-2 mutations may be associated with recurrent coronary artery disease due to acetylsalicylic acid resistance.
Synapse has enriched 10 related papers. Consider them for comparative context: